United Guardian (UG) Non Operating Income (2010 - 2026)
United Guardian's (UG) quarterly Non Operating Income came in at $163480.0 in Q2 2026, up 71.81% year-over-year from $95149.0 in Q2 2025, and down 58.16% quarter-over-quarter from $390689.0 in Q1 2026.
Analysis
United Guardian (UG) Non Operating Income (2010 - 2026) Analysis & Trends
United Guardian has disclosed Non Operating Income across 16 years of filings, most recently posting $163480.0 for Q2 2026.
- In Q2 2026, Non Operating Income rose 71.81% year-over-year to $163480.0; the TTM figure through Jun 2026 stood at $761650.0 (up 79.73% YoY), while the FY2025 annual figure was $399667.0, down 13.43% from the prior year.
- Non Operating Income came in at $163480.0 for Q2 2026 at United Guardian, down from $390689.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $390689.0 in Q1 2026 to a low of -$401418.0 in Q2 2022.
- Average Non Operating Income over 5 years is $55205.6, with a median of $96557.5 recorded in 2025.
- The largest YoY upside for Non Operating Income was 329.0% in 2022 against a maximum downside of 1958.87% in 2022.
- Over 5 years, Non Operating Income stood at $198509.0 in 2022, then slipped by 29.65% to $139659.0 in 2023, then tumbled by 39.54% to $84436.0 in 2024, then climbed by 13.79% to $96078.0 in 2025, then surged by 70.15% to $163480.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $163480.0 in Q2 2026, $390689.0 in Q1 2026, and $96078.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.06 Bn | 626.30 Bn | 17.26 Bn | - |
| 2 | AbbVie | 440.06 Bn | 433.49 Bn | 12.70 Bn | - |
| 3 | Merck | 364.19 Bn | 357.05 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 268.45 Bn | 260.76 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.40 Bn | 146.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.57 Bn | 45.19 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | -139.24 Mn |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.15 Bn | 18.49 Bn | 683.80 Mn | 41.90 Mn |
| 10 | United Guardian | 32.71 Mn | 23.12 Mn | 1.55 Mn | 163,480.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 163,480.00 |
| Mar 31, 2026 | 390,689.00 |
| Dec 31, 2025 | 96,078.00 |
| Sep 30, 2025 | 111,403.00 |
| Jun 30, 2025 | 95,149.00 |
| Mar 31, 2025 | 97,037.00 |
| Dec 31, 2024 | 84,436.00 |
| Sep 30, 2024 | 147,157.00 |
| Jun 30, 2024 | 90,506.00 |
| Mar 31, 2024 | 139,569.00 |
| Dec 31, 2023 | 139,659.00 |
| Sep 30, 2023 | 65,325.00 |
| Jun 30, 2023 | 62,429.00 |
| Mar 31, 2023 | 120,333.00 |
| Dec 31, 2022 | 198,509.00 |
| Sep 30, 2022 | -253,531.00 |
| Jun 30, 2022 | -401,418.00 |
| Mar 31, 2022 | -353,110.00 |
| Dec 31, 2021 | 46,273.00 |
| Sep 30, 2021 | 13,639.00 |